University of California San Francisco

A randomized, double-blind, placebo-controlled proof of concept trial of topical cidofovir, 1% and 3%, for the prevention of beard hair growth in men. (22351834)

Wan J, Vittorio CC, Abuabara K, Kurd SK, Musiek A, Steinemann JM, Gelfand JM PMID: 22351834

Association of systemic psoriasis therapies and incidence of myocardial infarction: reply from authors. (21966952)

Abuabara K, Lee H, Kimball AB PMID: 21966952

Reliability and validity of a photographic method for measuring facial hair density in men. (22106126)

Wan J, Abuabara K, Kurd SK, Musiek A, Steinemann JM, Vittorio CC, Gelfand JM PMID: 22106126

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. (21777216)

Abuabara K, Lee H, Kimball AB PMID: 21777216

Dermatologist response rates to a mailed questionnaire: a randomized trial of monetary incentives. (22036576)

Wan J, Abuabara K, Shin DB, Troxel AB, Bebo BF, Gelfand JM PMID: 22036576

Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. (21856040)

Wan J, Abuabara K, Troxel AB, Shin DB, Van Voorhees AS, Bebo BF, Krueger GG, Callis Duffin K, Gelfand JM PMID: 21856040

The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. (21315483)

Dommasch ED, Abuabara K, Shin DB, Nguyen J, Troxel AB, Gelfand JM PMID: 21315483

Validity of The Health Improvement Network (THIN) for the study of psoriasis. (21073449)

Seminara NM, Abuabara K, Shin DB, Langan SM, Kimmel SE, Margolis D, Troxel AB, Gelfand JM PMID: 21073449

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. (20633008)

Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM PMID: 20633008

Diet and weight loss as a treatment for psoriasis. (20479304)

Gelfand JM, Abuabara K PMID: 20479304